Zyprexa documents ppt 4.

1
Zyprexa documents ppt 4.

• This powerpoint has a selection of pages from
  documents to do with managing Adverse Drug Event
  issues.

2
ZY100426128 US schizophrenia advisory panel
review HGAJ study with advisor comments Dec1995
3
ZY100074131 FDA warning letter Nov 1996
4
ZY100074131 FDA warning letter Nov 1996
5
ZY 100291752 European Agency for the Evaluation
of Medicinal Products fax 1998
6
ZY 100291752 European Agency for the Evaluation
of Medicinal Products fax 1998
7
ZY100291754 Lilly reply to Euro Agency for
Medicines 1998
8
ZY100363330 emails re German Sth African
hypergly/diabetes reports Mar1998
9
ZY100363330 emails re diabetes Sep1999
10
ZY100363361 Eli-Lilly review of spontaneous
hypergly reports 1999
11
ZY100363361 Eli-Lilly review of spontaneous
hypergly reports 1999
12
ZY100094522 internal Lilly email Dec1998 re
hyperglycaemia and diabetes
13
ZY100291761 review of hyperglycemia cases
reported in Lilly database Sep96 -Jun98
14
ZY100291761 review of hyperglycemia cases
reported in Lilly database Sep96 -Jun98
15
ZY100291761 review of hyperglycemia cases
reported in Lilly database Sep96 -Jun98
16
ZY100291761 review of hyperglycemia cases
reported in Lilly database Sep96 -Jun98
17
ZY100379985 ADEs report from early placebo
controlled trials 1997or later (large font in
document)
18
ZY100382455 form letter for ?doctors re
hypergly/diabetes aprox late 1999
19
ZY201016928/9letter re high rate diabetes Nov1999
20
ZY100363522 mtg minutes re in-house study re
diabetes Aug 1999
21
ZY100371941 Biological Psychiatry reviewers
comments Nov 2000
22
ZY100371941 Biological Psychiatry reviewers
comments Nov 2000
23
ZY100008867 Olz wght change int memo Dec1999
24
ZY100008867 Olz wght change int memo Dec1999
25
ZY100008867 Olz wght change int memo Dec1999
26
ZY100008867 Olz wght change int memo Dec1999
27
ZY100040198 verbatims for doctors re weight gain
28
ZY100040198 verbatims for doctors re weight gain
29
ZY100040198 verbatims for doctors re weight gain
30
ZY100040198 verbatims for doctors re weight gain
31
ZY100040198 verbatims for doctors re weight gain
32
ZY100040198 verbatims for doctors re weight gain
33
ZY100040198 verbatims for doctors re weight gain
34
ZY100134405 Statement re diabetes, wght gain Oct
2000
35
ZY100592565 Olanzapine core safety efficacy
beliefs summary undated. Notes EL trials not
designed to spec test re diabetes
36
ZY 100175585 Diabetes situation analysis Dec
2000
37
ZY 100175585 Diabetes situation analysis Dec
2000
38
ZY 100175585 Diabetes situation analysis Dec
2000
39
ZY 100175585 Diabetes situation analysis Dec
2000
40
ZY 100175585 Diabetes situation analysis Dec
2000
41
ZY 100175585 Diabetes situation analysis Dec
2000
42
ZY 100175585 Diabetes situation analysis Dec
2000
43
ZY 100175630 Minutes of expert consultant mtg re
diabetes and weight gain Aug 2000
44
ZY 100175630 Minutes of expert mtg Aug 2000
45
ZY 100175630 Minutes of expert mtg Aug 2000
46
ZY 100175630 Minutes of expert mtg Aug 2000
47
ZY100375967 Market research re doctors views
diabetes and antipsychotics Sep 2000
48
ZY100375967 Market research re doctors views
diabetes and antipsychotics Sep 2000
49
ZY100378053 email hyperglycaemia threat for
olanzapine Sep 2000
50
ZY100378054 emails re mtg with endocrinologic
consultants Oct 2000
51
ZY100378054 emails re mtg with endocrinologic
consultants Oct 2000
52
ZY100378059 emails re mtg with endocrinologic
consultants Oct 2000
53
ZY100378059 emails re mtg with endocrinologic
consultants Oct 2000
54
ZY100378059 emails re mtg with endocrinologic
consultants Oct 2000
55
ZY100378062 emails re mtg with endocrinologic
consultants Oct 2000
56
ZY100378070 emails re mtg with endocrinologic
consultants Oct 2000